MedPath

Florexa

Florexa

Approved
Approval ID

d0842c09-4f4f-5209-e053-2a95a90a54d6

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Dec 26, 2023

Manufacturers
FDA

Pella Pharmaceuticals Co. Ltd

DUNS: 562370925

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Eflornithine Hydrochloride

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code82160-125
Product Classification
G
Generic Name
Eflornithine Hydrochloride
Product Specifications
Route of AdministrationTOPICAL
Effective DateDecember 26, 2023
FDA Product Classification

INGREDIENTS (1)

EFLORNITHINE HYDROCHLORIDEActive
Quantity: 4170 mg in 30 g
Code: 4NH22NDW9H
Classification: ACTIR

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Florexa - FDA Drug Approval Details